{"&cites=13360512895833832804&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Safety, activity, and immune correlates of anti–PD-1 antibody in cancer","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1200690","authors":["SL Topalian","SL Topalian FS Hodi","SL Topalian FS Hodi JR Brahmer…"],"year":2012,"numCitations":9290,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1200690","citationUrl":"http://scholar.google.com/scholar?cites=10859371970938450815&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:f7Oeq0U9tJYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10859371970938450815&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc","p":1,"exp":1596881523786},{"title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association …","url":"https://www.liebertpub.com/doi/abs/10.1089/thy.2015.0020","authors":["BR Haugen","BR Haugen EK Alexander","BR Haugen EK Alexander KC Bible","BR Haugen EK Alexander KC Bible GM Doherty…"],"year":2016,"numCitations":6116,"pdf":"https://www.liebertpub.com/doi/pdfplus/10.1089/thy.2015.0020","citationUrl":"http://scholar.google.com/scholar?cites=324716588517407600&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:cLtBTwSggQQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=324716588517407600&hl=en&as_sdt=2005&sciodt=0,5","publication":"liebertpub.com"},{"title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","url":"https://www.nejm.org/doi/full/10.1056/nejmoa052306","authors":["MJ Piccart"],"year":2005,"numCitations":5369,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa052306","citationUrl":"http://scholar.google.com/scholar?cites=1796034903430917809&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:se4zlzrM7BgJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1796034903430917809&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"PD-1 blockade in tumors with mismatch-repair deficiency","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1500596","authors":["DT Le","DT Le JN Uram","DT Le JN Uram H Wang","DT Le JN Uram H Wang BR Bartlett…"],"year":2015,"numCitations":4854,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1500596","citationUrl":"http://scholar.google.com/scholar?cites=10258601064941698851&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Iz9L8FDfXY4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10258601064941698851&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Nivolumab plus ipilimumab in advanced melanoma","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1302369","authors":["JD Wolchok","JD Wolchok H Kluger","JD Wolchok H Kluger MK Callahan","JD Wolchok H Kluger MK Callahan MA Postow…"],"year":2013,"numCitations":3710,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1302369","citationUrl":"http://scholar.google.com/scholar?cites=14171047859475257990&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:hhoVX_KsqcQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14171047859475257990&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Pembrolizumab for the treatment of non–small-cell lung cancer","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1501824","authors":["EB Garon","EB Garon NA Rizvi","EB Garon NA Rizvi R Hui","EB Garon NA Rizvi R Hui N Leighl…"],"year":2015,"numCitations":3642,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1501824","citationUrl":"http://scholar.google.com/scholar?cites=4804110826968085903&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:j3UKB1ihq0IJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4804110826968085903&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","url":"https://www.nature.com/articles/nature13954?page=4","authors":["PC Tumeh","PC Tumeh CL Harview","PC Tumeh CL Harview JH Yearley","PC Tumeh CL Harview JH Yearley IP Shintaku…"],"year":2014,"numCitations":3357,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246418/","citationUrl":"http://scholar.google.com/scholar?cites=8600773541923439091&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:88Hsr_cVXHcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8600773541923439091&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Safety and tumor responses with lambrolizumab (anti–PD-1) in melanoma","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1305133","authors":["O Hamid","O Hamid C Robert","O Hamid C Robert A Daud","O Hamid C Robert A Daud FS Hodi…"],"year":2013,"numCitations":3154,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa1305133","citationUrl":"http://scholar.google.com/scholar?cites=164069860268346458&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:WoykK6vkRgIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=164069860268346458&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","url":"https://www.nature.com/articles/nature14011?page=1","authors":["RS Herbst","RS Herbst JC Soria","RS Herbst JC Soria M Kowanetz","RS Herbst JC Soria M Kowanetz GD Fine","RS Herbst JC Soria M Kowanetz GD Fine O Hamid…"],"year":2014,"numCitations":3082,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4836193/","citationUrl":"http://scholar.google.com/scholar?cites=16172811975131816039&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Z2Dq3M1eceAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16172811975131816039&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1411087","authors":["SM Ansell","SM Ansell AM Lesokhin","SM Ansell AM Lesokhin I Borrello…"],"year":2015,"numCitations":2576,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa1411087","citationUrl":"http://scholar.google.com/scholar?cites=9724708986138050565&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:BcDOlkwb9YYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9724708986138050565&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"}]}